Literature DB >> 7742557

Rapid Rh D genotyping by polymerase chain reaction-based amplification of DNA.

S Simsek1, B H Faas, P M Bleeker, M A Overbeeke, H T Cuijpers, C E van der Schoot, A E von dem Borne.   

Abstract

Rh (rhesus) D is the dominant antigen of the Rh blood group system. Recent advances in characterization of the nucleotide sequence of the cDNA(s) encoding the Rh D polypeptide allow the determination of the Rh D genotype at the DNA level. This can be of help in cases in which red blood cells are not available for phenotyping, eg, when in concerns a fetus. We have tested three independent DNA typing methods based on the polymerase chain reaction (PCR) for their suitability to determine the Rh D genotype. DNA derived from peripheral blood mononuclear cells from 234 Rh-phenotyped healthy donors (178 Rh D positive and 56 Rh D negative) was used in the PCR. The Rh D genotypes, as determined with a method based on the allele-specific amplification of the 3' noncoding region of the Rh D gene described by Bennett et al (N Engl J Med 329:607, 1993), were not concordant with the serologically established phenotypes in all cases. We have encountered 5 discrepant results, ie, 3 false-positive and 2 false-negative (a father and child). Rh D genotyping with the second method was performed by PCR amplification of exon 7 of the D gene with allele-specific primers. In all donors phenotyped as D positive tested so far (n = 178), the results of molecular genotyping with this method were concordant with the serologic results, whereas a false-positive result was obtained in one of the D-negative donors (also false-positive in the first method). Complete agreement was found between genotypes determined in the third method, based on a 600-bp deletion in intron 4 of the Rh D gene described by Arce et al (Blood 82:651, 1993), and serologically determined phenotypes. The Rh blood group system is complex, and unknown polymorphisms at the DNA level are expected to exist. Therefore, although genotypes determined by the method of Arce et al were in agreement with serotypes, it cannot yet be regarded as the golden standard. More experience with this or other methods is still needed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7742557

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Molecular-genetic variance of RH blood group system within human population of Bosnia and Herzegovina.

Authors:  Lejla Lasić; Naida Lojo-Kadrić; Elma Silajdžić; Lejla Pojskić; Rifat Hadžiselimović; Naris Pojskić
Journal:  Bosn J Basic Med Sci       Date:  2013-02       Impact factor: 3.363

2.  The RHD gene is highly detectable in RhD-negative Japanese donors.

Authors:  H Okuda; M Kawano; S Iwamoto; M Tanaka; T Seno; Y Okubo; E Kajii
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

3.  Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women.

Authors:  Christelle Rouillac-Le Sciellour; Philippe Puillandre; Rolande Gillot; Céline Baulard; Sylvain Métral; Caroline Le Van Kim; Jean-Pierre Cartron; Yves Colin; Yves Brossard
Journal:  Mol Diagn       Date:  2004

4.  Biologic properties and enucleation of red blood cells from human embryonic stem cells.

Authors:  Shi-Jiang Lu; Qiang Feng; Jennifer S Park; Loyda Vida; Bao-Shiang Lee; Michael Strausbauch; Peter J Wettstein; George R Honig; Robert Lanza
Journal:  Blood       Date:  2008-08-19       Impact factor: 22.113

5.  Molecular genotyping of clinically important blood group antigens in patients with thalassaemia.

Authors:  Swati Kulkarni; Bhavika Choudhary; Harita Gogri; Shashikant Patil; Mamta Manglani; Ratna Sharma; Manisha Madkaikar
Journal:  Indian J Med Res       Date:  2018-12       Impact factor: 2.375

6.  Human finger-prick induced pluripotent stem cells facilitate the development of stem cell banking.

Authors:  Hong-Kee Tan; Cheng-Xu Delon Toh; Dongrui Ma; Binxia Yang; Tong Ming Liu; Jun Lu; Chee-Wai Wong; Tze-Kai Tan; Hu Li; Christopher Syn; Eng-Lee Tan; Bing Lim; Yoon-Pin Lim; Stuart A Cook; Yuin-Han Loh
Journal:  Stem Cells Transl Med       Date:  2014-03-19       Impact factor: 6.940

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.